HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies
Immunological Reviews · 2025-01 · 329 (1)
DOI: 10.1111/imr.13434 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 03.01.2025. Verfasst von Geraldine M Gillespie und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Medicine, Center for Immuno-Oncology, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, HLA-E Antigens, Killer Cells, Natural, Protein Binding. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Health (USA), Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
HLA‐E is a nonclassical, nonpolymorphic, class Ib HLA molecule. Its primary function is to present a conserved nonamer peptide, termed VL9, derived from the signal sequence of classical MHC molecules to the NKG2x‐CD94 receptors on NK cells and a subset of T lymphocytes. These receptors regulate the function of NK cells, and the importance of this role, which is conserved across mammalian species, probably accounts for the lack of genetic polymorphism. A second minor function is to present other, weaker binding, pathogen‐derived peptides to T lymphocytes. Most of these peptides bind suboptimally to HLA‐E, but this binding appears to be enabled by the relative stability of peptide‐free, but receptive, HLA‐E‐β2m complexes. This, in turn, may favor nonclassical antigen processing that may be associated with bacteria infected cells. This review explores how the structure of HLA‐E, bound to different peptides and then to NKG2‐CD94 or T‐cell receptors, relates to HLA‐E cell biology and immunology. A detailed understanding of this molecule could open up opportunities for development of universal T‐cell and NK‐cell‐based immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuffield Department of Medicine, Center for Immuno-Oncology, University of Oxford, Oxford, UK.
ORCID-Profile: Geraldine M Gillespie
Förderung
- NIAID NIH HHS
- National Institute of Health (USA)
- Bill and Melinda Gates Foundation
- Wellcome Trust
Zitieren
APA
Gillespie, G. M., Quastel, M. N., & McMichael, A. J. (2025). HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies. Immunological Reviews, 329(1). https://doi.org/10.1111/imr.13434
Vancouver
Gillespie GM, Quastel MN, McMichael AJ. HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies. Immunological Reviews. 2025;329(1). doi:10.1111/imr.13434
BibTeX
@article{Gillespie2025,
author = {Gillespie, Geraldine M and Quastel, Max N and McMichael, Andrew J},
title = {HLA ‐E: Immune Receptor Functional Mechanisms Revealed by Structural Studies},
journal = {Immunological Reviews},
year = {2025},
volume = {329},
number = {1},
doi = {10.1111/imr.13434}
}
EUVIMED